COMPOSITIONS AND METHODS FOR ENHANCING IMMUNE RESPONSE TO VACCINATION AND IMPROVING VACCINE PRODUCTION

Miltefosine is utilized to enhance immune response to vaccination, for example an influenza and/or coronavirus vaccination. The inventive subject matter also provides compositions and methods for enhancing viral yield in cultured cells, by application of a cannabinoid receptor agonist (such as methanandamide) to such cells. Such enhanced viral yield can be used to enhance virus production for purposes of vaccine formulation and/or to improve sensitivity of cell-based virus assays..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 19. Apr. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

YUEN KWOK YUNG [VerfasserIn]
TO KAI WANG KELVIN [VerfasserIn]
YUAN SHUOFENG [VerfasserIn]
CHAN FUK WOO JASPER [VerfasserIn]
ZHANG JINXIA [VerfasserIn]
HUNG FAN NGAI [VerfasserIn]
LAU JOHNSON YIU-NAM [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
bio
C12N: Microorganisms or enzymes; compositions thereof; pr (...)
C12Q: Measuring or testing processes involving enzymes, n (...)
che
G01N: Investigating or analysing materials by determining (...)
tec

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-04-19, Last update posted on www.tib.eu: 2023-07-06, Last updated: 2023-07-14

Patentnummer:

EP3908315

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA014009587